97 related articles for article (PubMed ID: 15659500)
1. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
Laver JH; Kraveka JM; Hutchison RE; Chang M; Kepner J; Schwenn M; Tarbell N; Desai S; Weitzman S; Weinstein HJ; Murphy SB
J Clin Oncol; 2005 Jan; 23(3):541-7. PubMed ID: 15659500
[TBL] [Abstract][Full Text] [Related]
2. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Patte C; Auperin A; Gerrard M; Michon J; Pinkerton R; Sposto R; Weston C; Raphael M; Perkins SL; McCarthy K; Cairo MS;
Blood; 2007 Apr; 109(7):2773-80. PubMed ID: 17132719
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
Kersten MJ; Kraan W; Doorduijn J; Bromberg J; Lam K; Kluin PM; van der Holt BJ; Spaargaren M; Pals ST
Blood Cancer J; 2014 Dec; 4(12):e266. PubMed ID: 25501023
[No Abstract] [Full Text] [Related]
4. Methotrexate induced lung injury in a patient with primary CNS lymphoma: a case report.
Chhabra P; Law AD; Suri V; Malhotra P; Varma S
Mediterr J Hematol Infect Dis; 2012; 4(1):e2012020. PubMed ID: 22550565
[TBL] [Abstract][Full Text] [Related]
5. Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.
Le Deley MC; Rosolen A; Williams DM; Horibe K; Wrobel G; Attarbaschi A; Zsiros J; Uyttebroeck A; Marky IM; Lamant L; Woessmann W; Pillon M; Hobson R; Mauguen A; Reiter A; Brugières L
J Clin Oncol; 2010 Sep; 28(25):3987-93. PubMed ID: 20679620
[TBL] [Abstract][Full Text] [Related]
6. Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.
Brugières L; Le Deley MC; Rosolen A; Williams D; Horibe K; Wrobel G; Mann G; Zsiros J; Uyttebroeck A; Marky I; Lamant L; Reiter A
J Clin Oncol; 2009 Feb; 27(6):897-903. PubMed ID: 19139435
[TBL] [Abstract][Full Text] [Related]
7. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Alexander S; Kraveka JM; Weitzman S; Lowe E; Smith L; Lynch JC; Chang M; Kinney MC; Perkins SL; Laver J; Gross TG; Weinstein H
Pediatr Blood Cancer; 2014 Dec; 61(12):2236-42. PubMed ID: 25156886
[TBL] [Abstract][Full Text] [Related]
8. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial.
Wrobel G; Mauguen A; Rosolen A; Reiter A; Williams D; Horibe K; Brugières L; Le Deley MC;
Pediatr Blood Cancer; 2011 Jul; 56(7):1071-7. PubMed ID: 21280197
[TBL] [Abstract][Full Text] [Related]
9. Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology.
Brugières L; Pacquement H; Le Deley MC; Leverger G; Lutz P; Paillard C; Baruchel A; Frappaz D; Nelken B; Lamant L; Patte C
J Clin Oncol; 2009 Oct; 27(30):5056-61. PubMed ID: 19738127
[TBL] [Abstract][Full Text] [Related]
10. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Link MP; Shuster JJ; Donaldson SS; Berard CW; Murphy SB
N Engl J Med; 1997 Oct; 337(18):1259-66. PubMed ID: 9345074
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
Witzig TE; Wiernik PH; Moore T; Reeder C; Cole C; Justice G; Kaplan H; Voralia M; Pietronigro D; Takeshita K; Ervin-Haynes A; Zeldis JB; Vose JM
J Clin Oncol; 2009 Nov; 27(32):5404-9. PubMed ID: 19805688
[TBL] [Abstract][Full Text] [Related]
12. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.
Marcus R; Imrie K; Solal-Celigny P; Catalano JV; Dmoszynska A; Raposo JC; Offner FC; Gomez-Codina J; Belch A; Cunningham D; Wassner-Fritsch E; Stein G
J Clin Oncol; 2008 Oct; 26(28):4579-86. PubMed ID: 18662969
[TBL] [Abstract][Full Text] [Related]
13. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
Robinson KS; Williams ME; van der Jagt RH; Cohen P; Herst JA; Tulpule A; Schwartzberg LS; Lemieux B; Cheson BD
J Clin Oncol; 2008 Sep; 26(27):4473-9. PubMed ID: 18626004
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
[TBL] [Abstract][Full Text] [Related]
15. Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.
Horwitz EM; Bae K; Hanks GE; Porter A; Grignon DJ; Brereton HD; Venkatesan V; Lawton CA; Rosenthal SA; Sandler HM; Shipley WU
J Clin Oncol; 2008 May; 26(15):2497-504. PubMed ID: 18413638
[TBL] [Abstract][Full Text] [Related]
16. Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
Friedberg JW; Cohen P; Chen L; Robinson KS; Forero-Torres A; La Casce AS; Fayad LE; Bessudo A; Camacho ES; Williams ME; van der Jagt RH; Oliver JW; Cheson BD
J Clin Oncol; 2008 Jan; 26(2):204-10. PubMed ID: 18182663
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study.
Le Deley MC; Reiter A; Williams D; Delsol G; Oschlies I; McCarthy K; Zimmermann M; Brugières L;
Blood; 2008 Feb; 111(3):1560-6. PubMed ID: 17957029
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
Czuczman MS; Koryzna A; Mohr A; Stewart C; Donohue K; Blumenson L; Bernstein ZP; McCarthy P; Alam A; Hernandez-Ilizaliturri F; Skipper M; Brown K; Chanan-Khan A; Klippenstein D; Loud P; Rock MK; Benyunes M; Grillo-Lopez A; Bernstein SH
J Clin Oncol; 2005 Feb; 23(4):694-704. PubMed ID: 15681517
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.
Lowe EJ; Sposto R; Perkins SL; Gross TG; Finlay J; Zwick D; Abromowitch M;
Pediatr Blood Cancer; 2009 Mar; 52(3):335-9. PubMed ID: 18985718
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]